Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

From Endothelial Survival to Lung Protection: Calycosin Attenuates Ischemia–Reperfusion Injury

  1. 1Department of Thoracic Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China
  2. 2Key Laboratory of Enhanced Recovery After Surgery of Integrated Chinese and Western Medicine, Administration of Traditional Chinese Medicine of Shaanxi Province, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China

Abstract

Lung ischemia–reperfusion injury (LIRI) contributes to early graft dysfunction after lung transplantation, yet effective pharmacological interventions remain limited. Calycosin (CA), an isoflavone sourced from Astragali Radix, has shown protective effects in experimental ischemic injury, but its effects on LIRI remain insufficiently characterized. We integrated network analysis and molecular docking with experiments in human umbilical vein endothelial cells subjected to oxygen–glucose deprivation/reoxygenation (OGD/R) and male Sprague–Dawley rats undergoing left pulmonary hilar occlusion and reperfusion. Computational analyses highlighted inflammatory signaling, redox regulation, and cell survival, with CA improving endothelial viability and reducing oxidative stress, apoptosis, and inflammatory cytokine levels. In rats, CA reduced histological injury, edema, inflammatory cell accumulation, and lipid peroxidation while improving arterial oxygenation, superoxide dismutase activity, and tissue ATP content. Protection was accompanied by changes in candidate gene expression and PPARγ, COX-2, BAX, and BCL2 protein abundance. In endothelial cells, the PPARγ antagonist GW9662 attenuated the protective effects of CA and its reduction of NF-κB p65 nuclear accumulation. These findings support CA’s potential as a candidate intervention for LIRI and identify PPARγ as a contributor to its endothelial–protective effects, providing a rationale for further evaluation in lung preservation and transplantation models.

Related

  1. Arctigenin Attenuates Hepatic Ischemia/Reperfusion Injury by Enhancing NRF2-GST/GPX4 Antioxidant Response
    Zhe Wang, Ruishuo Liang, Mingshun Xu +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  2. Carnosic Acid Attenuates Lipotoxicity-Mediated Myocardial Ischemia–Reperfusion Injury by Suppressing Complex I ROS and Modulating the SIRT1–UPRmt Axis
    Xiaobing Shi, Man Wang, Xiaowei Zhou +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  3. Inhibition of Endothelial Phosphodiesterase 2A Attenuates Post-infarct Inflammation.
    Virta V Wagde, Zihou Liu, Annika Schlemper +12
    JACC. Basic to translational sciencePeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMC
  4. Macrophage‐Derived Glycoprotein Nonmetastatic Melanoma Protein B Attenuates Cardiac Dysfunction by Promoting Vascular Endothelial Growth Factor‐Independent Angiogenesis
    Haihuan Lin, Zhihui Yang, Chi Zhang +5
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationCrossrefDOAJ
  5. Conditioned medium from Sanhuang Decoction-pretreated MDA-MB-231 cells attenuates endothelial inflammation and barrier dysfunction
    Ke Hong, Shuqin Li, Cong Wang +2
    Frontiers in Molecular BiosciencesPeer-reviewedCC BY 4.0Molecular biology & gene regulationFrontiers
BibTeX
@article{zhao2026from,
  title = {{From Endothelial Survival to Lung Protection: Calycosin Attenuates Ischemia–Reperfusion Injury}},
  author = {Heng Zhao and Zhe Chen and Chi Wang and Yixing Li and Yihan Lin and Hongyi Wang and Ming Li and Jinteng Feng and Guangjian Zhang},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms272210275},
  url = {https://www.mdpi.com/1422-0067/27/22/10275},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - From Endothelial Survival to Lung Protection: Calycosin Attenuates Ischemia–Reperfusion Injury
AU  - Heng Zhao
AU  - Zhe Chen
AU  - Chi Wang
AU  - Yixing Li
AU  - Yihan Lin
AU  - Hongyi Wang
AU  - Ming Li
AU  - Jinteng Feng
AU  - Guangjian Zhang
PY  - 2026
DA  - 2026/11/16
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms272210275
UR  - https://www.mdpi.com/1422-0067/27/22/10275
AB  - Lung ischemia–reperfusion injury (LIRI) contributes to early graft dysfunction after lung transplantation, yet effective pharmacological interventions remain limited. Calycosin (CA), an isoflavone sourced from Astragali Radix, has shown protective effects in experimental ischemic injury, but its effects on LIRI remain insufficiently characterized. We integrated network analysis and molecular docking with experiments in human umbilical vein endothelial cells subjected to oxygen–glucose deprivation/reoxygenation (OGD/R) and male Sprague–Dawley rats undergoing left pulmonary hilar occlusion and reperfusion. Computational analyses highlighted inflammatory signaling, redox regulation, and cell survival, with CA improving endothelial viability and reducing oxidative stress, apoptosis, and inflammatory cytokine levels. In rats, CA reduced histological injury, edema, inflammatory cell accumulation, and lipid peroxidation while improving arterial oxygenation, superoxide dismutase activity, and tissue ATP content. Protection was accompanied by changes in candidate gene expression and PPARγ, COX-2, BAX, and BCL2 protein abundance. In endothelial cells, the PPARγ antagonist GW9662 attenuated the protective effects of CA and its reduction of NF-κB p65 nuclear accumulation. These findings support CA’s potential as a candidate intervention for LIRI and identify PPARγ as a contributor to its endothelial–protective effects, providing a rationale for further evaluation in lung preservation and transplantation models.
SN  - 1422-0067
ER  -